Body

Pancreatic cancer patient survival 'significantly higher' with nab-paclitaxel, says TGen-led study

SCOTTSDALE, Ariz. — Oct. 16, 2013 — By all measures, the addition of nab-paclitaxel for the treatment of patients with advanced pancreatic cancer was superior to the survival for patients who received only gemcitabine, according to the results of a study led by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare, published today by The New England Journal of Medicine.

Rapid blood test to diagnose sepsis at the bedside could save thousands of lives, study suggests

Researchers at King's College London have identified a biomarker – a biological 'fingerprint' – for sepsis in the blood, and showed it could be possible to diagnose the condition within two hours by screening for this biomarker at a patient's bedside.

Separating the good from the bad in bacteria

CAMBRIDGE, MA -- There are good bacteria and there are bad bacteria -- and sometimes both coexist within the same species.

Take, for instance, Pseudomonas aeruginosa, a microbe common in soil and water. This bacterium has been found to colonize medical equipment in hospitals and clinics around the world, and can live benignly in healthy individuals. But the bug poses a risk to those with weakened immune systems, and can turn pathogenic in patients with cystic fibrosis, forming thick layers of mucus in the lungs.

Bariatric surgery patients not being prioritized correctly

Most people who receive bariatric surgery in Canada, and around the world, are obese women, even though their male counterparts are more at risk, especially if those men are smokers and have diabetes. These findings are demonstrated in newly published medical research from the University of Alberta.

Study suggests: Blood test can differentiate between benign lung nodules and early stage lung cancer

SEATTLE, October 16, 2013 – Indi (Integrated Diagnostics), an emerging leader in molecular diagnostics, today announced the results of a major study which suggests that quantifying a combination of blood proteins can distinguish between benign lung nodules and early-stage lung cancer with high probability.

Using mobile devices to look up drug info prevents adverse events in nursing homes

PITTSBURGH, Oct. 16, 2013 – Nearly nine out of 10 nursing home physicians said that using their mobile devices to look up prescription drug information prevented at least one adverse drug event in the previous month, according to a University of Pittsburgh School of Medicine Department of Biomedical Informatics study published last week in the Journal of the American Medical Directors Association.

Genetic errors identified in 12 major cancer types

Examining 12 major types of cancer, scientists at Washington University School of Medicine in St. Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body. The discovery sets the stage for devising new diagnostic tools and more personalized cancer treatments.

Researchers discover and treat toxic effects of ALS mutation in neurons made from patients' skin cells

Researchers have discovered how the most common genetic abnormality in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) kills neurons and have successfully developed a therapeutic strategy to block this neurodegeneration in neurons made from the skin cells of ALS patients. The findings, which are published online in the October 16th issue of the Cell Press journal Neuron, have important implications for treating patients with these debilitating, currently incurable neurodegenerative diseases.

Study shows how Staph toxin disarms the immune system

Researchers at NYU Langone Medical Center have discovered a new mechanism by which the deadly Staphylococcus aureus bacteria attack and kill off immune cells. Their findings, published today in the journal Cell Host & Microbe, explain a critical survival tactic of a pathogen that causes more skin and heart infections than any other microbe, and kills more than 100,000 Americans every year.

Tracking viral DNA in the cell

The medical, humanitarian and economical impact of viral diseases is devastating to humans and livestock. There are no adequate therapies available against most viral diseases, largely because the mechanisms by which viruses infect cells are poorly known. An interdisciplinary team of researchers from the University of Zurich headed by cell biologist Prof. Urs Greber now presents a method that can be used to display viral DNA in host cells at single-molecule resolution.

Wari, predecessors of the Inca, used restraint to reshape human landscape

The Wari, a complex civilization that preceded the Inca empire in pre-Columbia America, didn't rule solely by pillage, plunder and iron-fisted bureaucracy, a Dartmouth study finds. Instead, they started out by creating loosely administered colonies to expand trade, provide land for settlers and tap natural resources across much of the central Andes.

Finding blood clots before they wreak havoc

CAMBRIDGE, Mass-- Life-threatening blood clots can form in anyone who sits on a plane for a long time, is confined to bed while recovering from surgery, or takes certain medications.

There is no fast and easy way to diagnose these clots, which often remain undetected until they break free and cause a stroke or heart attack. However, new technology from MIT may soon change that: A team of engineers has developed a way to detect blood clots using a simple urine test.

Toward a urine test for detecting blood clots

Detecting dangerous blood clots, which can cause life-threatening conditions such as strokes and heart attacks, leading causes of death for men and women in the U.S., has been a coveted and elusive goal. But scientists are now reporting progress in the form of a simple urine test. Their study, in which they demonstrated that the test works using laboratory mice, appears in the journal ACS Nano.

Light triggers death switch in cancer cells

Researchers at Cardiff University have created a peptide (a small piece of protein), linked to a light-responsive dye, capable of switching 'on' death pathways in cancer cells. The peptide remains inactive until exposed to external light pulses which convert it into a cell death signal.

Complex mechanisms in healthy cells normally protect us from developing cancer. However, when the finely balanced networks of interactions between proteins that control such mechanisms are disturbed, uncontrolled cell growth can occur.

Maximizing broccoli's cancer-fighting potential

Spraying a plant hormone on broccoli — already one of the planet's most nutritious foods — boosts its cancer-fighting potential, and researchers say they have new insights on how that works. They published their findings, which could help scientists build an even better, more healthful broccoli, in ACS' Journal of Agricultural & Food Chemistry.